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Abstmct Persistence of unique rabies virus variants in a diverse array of terrestrial carnivores and insectivorous bats makes rabies
control in the U S . a complcx task The public health systcm in the U.S. ic effective in keeping human deaths near zcro each year in
the face of cnzootic wildlife rabies, hut the annual cost of coexistence with the J k . is high, exceeding $300 million. In addition,
each year tens of thousands of people are impacted by anxiety, fear, and trauma associated with potential or actual rabies exposure to
themselves and their domestic animals. Exclusion, proper storage and disposal of garbage, and removal of problem animals are often
effectivealternatives to address wildlife rabies threats at specific sites; however, oral rabies vaccination (ORV) is the only currently
available technique that shows promise for wildlife rabies control on a broad geographic and species scale. In this paper, we discuss
progress toward using ORV to contain specific terrestrial rabies vhs variants in the U.S. and planning towards coordinated national
effortsto explore the elimination of terrestrial variants of rabies vhsin the U.S.
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INTRODUCllON
Rabies is one of the oldest recorded infectious
diseases. It is an acute, fatal encephalitis caused by a
virus that is almost always transmitted by the bite of a
rabid animal. Worldwide, rabies is estimated to cause
50,000 to 70,000 human deaths annually (Meslin et al.
1994). However, human rabies deaths in the U.S. and
other developed countries annually approach zero as the
result of effective, integrated public health programs that
rely on public health education, rabies surveillance, case
investigation, efficient and accurate laboratory diagnosis,
pet vaccination programs, and safe and effective postexposure prophylaxis.
During the early 19605, wild mammals emerged as
the mast frequently reported animals infected with rabies
in the U.S., replacing the domestic dog as the dominant
reservoirs for the v i m w e b s et al. m 1 ) . For the past
decade or more, wildlife-prhdy terrestrial carnivores
and insectivorous bats-have accounted for at least 90 %
of all animal rabies cases reported in the U.S. and Puerto
Rico. The persistence of rabies virus among diverse
carnivore and bat species greatly confounds rabies
control.
In spite of a public health strategy that is effective in
preventing human rabies deaths in the U.S., the financial
cost of coexistence with wildlife rabies is high, exceeding
$300 million annually (Fishbeii and R o b i n 1993).

Anxiety, fear, and trauma are examples of less easily
quantifiable impacts to humans associated with rabies
threats to people and their pets and livestock (Meltzer and
Rupprecht 1998 a, b; McQuiston et al. 2001).
Rabies viruses occur in the wild as unique variants
adapted to specific species or geographic areas occupied
by a reservoir species (Smith et al. 1992) (Figure 1). The
most frequently reported species with rabies in the U.S.
are the raccoon (Procyon lotor) and skunk (primarily
striped skunks, Mephitis mephitis) (Figure 2).
Insectivorous bats (Chiroptera spp.); arctic fox (Alopen
lagopus), red fox (Vulpes vulpes), and gray fox (Urocyon
cinereoargenreus); and coyote (Canis latrans) are also
important reservoirs for the vim, as is the small Indian
mongoose (Herpestes auropunctatus) in Puerto Rico
(Krebs et al. 2000). Although "spillover" of the virus has
been reported in several mammalian taxa, including
rodents and deer (Childs et al. 1997, Krebs et al. m l ) ,
additional reservoir species have not been documented
(Smith 1996).
Many challenges to contemporary rabies control
programs underscore the need for collaboration among
multiple disciplines. These include: varying ecological,
behavioral and biological attributes of diverse wildlife
rabies reservoirs; the effective application of oral
vaccines; environmental compliance; conducting
meaningful research to address existing data gaps; and

Figure 1. Distribution of terrestrial reservoirs of rabies in the United States (adapted from CDC map in Krebs et al.
2000).
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Figure 2. Frequency of rabies in important wildlife reservoirs during 1999 in the U.S. (adapted from CDC, Krebs et
al. 2000).
economic accountability. Cooperation among federal,
state, county, and municipal agencies with differing
missions and perspectives in hun place increased
emphasis on the need for sound communication and
wordination among partners. The limitation associated
with only a single licensed oral vaccine (Hanlon and
Rupprecht 1998) and the spechum of public attitudes
toward wildlife and rabies control with ORV (Siemer and
Brown 1994, Meltzer et al. 1997) also contribute to the
challenge of wildlife rabies control on a large scale.
Hanlon et al. (1999) discussed the potential
applicability of passive wildlife rabies surveillance,

habitat modification, population suppression (local and
broad scale), contraception, trapvaccinate-release, and
oral vaccination as rabies control alternatives. While each
approach may have applicability independently or when
integrated into a strategy, our discussion will focus on
ORV during the past decade with the objective of
providing an update of activities, accomplishments, and
planning directed toward control of specific te~~estrial
rabies virus variants in the U.S.

ORV MECHANISM AND STRATEGIES
The mechanisms for oral vaccine to immunize

individual animals essentially involve replication of the
virus in the animal's mouth (Wandeler 1991). Once the
immune system is sensitized, immunocompetent
individuals produce rabies virus neutralizing antibodies,
which are an effective means of protection against
productive infection (Orciari et al. 2001, Lamhot et al.
2m
1,).
-.-

At the wildlife population level, ORV programs are
designed to achieve sufficient population (herd) immunity
to meet rabies control goals. Goals may include
preventing spread of specific rabies virus variants to new
geographic areas, reducing the number of positive cases in
defmed enzootic areas, or eliminating specific variants
from some or all of their existing range.
Elimination represents an ideal goal for some rabies
virus variants, with success depending on a myriad of
factors. Key factors include: 1) access to safe, effective
and inexpensive vaccines; 2) availability of attractive,
target-specific baits; 3) sufficiently sensitive surveillance
to delineate epizootic rabies fronts, as well as to identify
rabies foci in e m t i c areas requiring timely treatment; 4)
favorable geographic features, such as mountains and
large bodies of water to help spatially frame ORV
strategies; 5) dependable and adequate funding to guard
against administrative failures; and 6) adequate
documentation and confidence in the anticipated financial
and social benefits to be derived from specific ORV
programs.
Prior to the development and application of
monoclonal antibodies in the late 1970s (Wiktor and
Kopowski 1978), rabies was thought to occur as a single
undifferentiated virus strain.
Use of monoclonal
antibodies has led to the identification of unique rabies
virus variants adapted to "cycle" within specific wildlife
species (Smith 1989). This enhanced understanding of
the dynamics of wildlife rabies has in turn led to
application of ORV strategies that can be focused on the
species that act as reservoirs for specific virus variants.

ORV HISTORY
Late 1960sto 1994
The concept of ORV was conceived at the Centers
for Disease Control and Prevention (CDC) and proven to
be feasible in the red fox (Baer et al. 1971). Switzerland
was the first count~yto use oral vaccine in the field in an
attempt to control rabies in red foxes (Steck et al. 1982).
Since that time, research has led to the development and
implementation of ORV programs in several Westem
European countries (Aubert et al. 1994, Stohr and M e s h
1996). ORV programs using either attenuate4 rabies
vaccines or the recombinant Raboral V-RG have
resulted in several European countries being designated
freeof rabies (Wandeler 2000, ZanoN et al. 2000).
In North America, the Province of Ontario, Canada
expanded research during the mid-1970s to evaluate the
prospect of using ORV to eliminate rabies that became
established in red foxes in the southem part of the
Province during the late 1950s (MacInnes and LeBer

2000). Since 1989, the Ontario Ministry of Natural
Resources has aerially distributed about 12 million baits
containing an attenuated rabies virus (EX4 vaccine) that
has reduced rabies in foxes by more than 97% (MacInnes,
pers. corn.).
Although the ability to vaccinate wildlife orally
against rabies was conceived and first tested under captive
conditions in the U.S., field application of this technology
has progressed at a more conservative pace than in
Europe and Canada. The slower pace at which ORV has
been embraced in the U.S. may be attributed in part to
several factors, including a medical system in which the
monetary costs associated with rabies are often not well
documented and diffuse, masking the cumulative
financial impact of wildlife rabies. Although postexposure prophylaxis is relatively expensive at about
$2,000 (Krebs et al. 1998), access to effective vaccines to
protect humans who may be exposed, often en masse
(Noah et al. 1996), and minimize the number of rabiesrelated deaths may create ambivalence toward the need
for ORV. Philosophical opposition to oral vaccination as
a prospective wildlife management method for any
purpose, let alone to achieve improved public health and
long-term financial savings, likely also has had an effect
on use of ORV in the U.S. The relatively high costs of
ORV in the face of competition for resources has
influenced budgetary support for programs Finally,
uncertainty of long-term technical success remains a
concern that can only be removed by the favorable
outcome of current ORV projects. In spite of a more
metered enthusiasm for ORV in the U.S., the success of
early field safety and efficacy trials with V-RG in
Virginia (Hanlon et al. 1998), Pennsylvania (Hanlon and
Rupprecht 1998) and New Jersey (Roscoe et al. 1998)
during the late 1980s and garly 1990s, supported the
licensing of Rahoral V-RG - the only licensed oral
vaccine for use in wildlife in the U.S. The commercial
availab'ity of this vaccine and support for limited
programs in tum facilitated the initiation of ORV projects
(Hanlon and Rupprecht 1998) in Ohio (Smith et al. 1999),
New York (Bigler, pers. comm.; Eidson, pers. comm.),
Vermont (Bigler, pers. comm.), Maryland (Ho-,
pers.
comm.), Massachusetts (Robhim et al. 1998), Florida
(Olson et al. WOO) and Texas (Feameyhough et al. 1998)
that are the building blocks for scientific evaluation and
refinement for future programs.
1994 to 2001
The ORV initiatives that followed the inaugural field
trials in Virginia, Pennsylvania, and New Jersey were
undertaken by state or county governments or
universities, with limited technical and financial support
provided either by CDC or USDA APHIS Wildlife
Senices (WS), or a combination from both federal
sources. With mounting U.S. Congressional support in
1997, WS received a federal appropriation in FY 1998 to
participate in cooperative ORV in Texas, Ohio, Vermont,
and New York uable 1). WS used these resources to

help meet the needs for each cooperative program,
including contracting for air services to distribute baits,
assistance with hand and aerial bait distribution, purchase
of baits, and providing wildlife management expertise in
sampling wildlife for post-vaccination evaluation.
To better ensure strategic ORV planning that would
lead to greater program stability and effectiveness, WS
formed a Rabies Management Team in 1997 composed of
WS operations and research personnel (National Wildlife
Research Center-NWRC), other APHIS expertise, and
external expertise from CDC, cooperating states, and
universities. The team was designed to bring together a
coalition of expertise from multiple disciplines to
establish short- and long-term program goals, strategically
plan to meet those goals, and prioritize research to
systematically address questions that would contribute to
enhanced ORV effectiveness. The Rabies Management
Team meets annually and communicates via conference
calls and email throughout the year on key issues.
In 1999, as a result of confirmed index cases of
raccoon rabies in southern Ontario (Rosatte et al. 2001),
the threat of raccoon rabies moving south and west
around the Ohio vaccination barrier, and reduced state
funding for the gray fox ORV project in Texas (Figure 3),
WS formulated a funding strategy based on input from
cooperators to secure additional resources through the
regular appropriations process as well as from emergency
sources (Commodity Credit Corporation [CCC] and
APHIS Contingency Fund). The distribution and spread
of raccoon variant of rabies, in particular, necessitated this
action given that states could not succeed independently
in meeting regional and national rabies control goals.
Clearly, long-term success of ORV would require
increased federal support and leadership to bring multiple
states together in a coordinated strategy.
Table 1. Recent USDA APHIS Wildlife Services funding
history for rabies control.
Federal
flscai year

Funding level
($ millions)

1998
1999
2000
2001

1.3,
1.8
1 .72
7.13

2002

18.3~

2003

25.5'

Geographic area specified
NY, OH, TX,VT
NY, OH, TX, VT
NY, OH, TX, VT
NY, OH, VT, WV,
states, T X
NY, OH. VT, WV,
states, TX, WY
NY, OH, VT, WV,
states, TX, WY

' includes $225.000 horn the APHIS Contingency

2.

eastern
eastern
eastern

Includes $65,000 of APHIS funds
Includes $4.1 million in Comrnoditv Credit Cornoration funds
'Includes $6 5 million in ~ornrnod~hl
Credlt ~o&ration funds
Based on projection from the Presidenrs Budget Proposal of
$13 7 rnllllon Increase

The following recommended course of action was
pursued by WS in response to feedback from five
stakeholder meetings held from December 1999 - May
UMO: 1) expand vaccination zones along the Canadian
border with New York and Vermont, and to vaccinate for
the first time the upper Connecticut River Valley between
Vermont and New Hampshire to contain raccoon variant
from extending its range northward; 2) extend the current
Ohio vaccination zone south into West Virginia, tying to
the Appalachian Mountains to prevent raccoon variant
form spreading west; and 3) provide additional
cooperative federal funding to assist Texas in restoring
the ORV gray fox project to its previous scope.
Jn response to external cooperator support, WS
received an increase in appropriated and emergency
funding through CCC funds to implement the proposed
ORV expansion to contain raccoon and gray fox rabies
(Table 1). To conduct these initiatives in 2001, WS
completed a programmatic environmental assessment to
comply with the National Environmental Policy Act
(NEPA) requirements (USDA 2031). Public input
provided for under NEPA was favorable and the projects
were completed as proposed (Figure 4). Environmental
compliance at all levels of government will continue to be
essential for the operation of long-term ORV programs.
The establishment of a Memorandum of
Understanding between the Rabies Section at CDC and
WS was a key initiative completed in 2000 that is
designed to enhance cooperation among all parties
involved or likely to become involved in ORV.
Fonnaliing this relationship facilitates c o m b i n g
wildlife management expertise in WS with the federal
public health infrastructure already in place at CDC in the
form of special ORV expertise, epidemiological
investigation, training, and reference laboratory support
critical to long-term program success. Interagency
agreements between CDC and WS are currently in place
to help augment critical funding needs to meet increasing
requests for assistance with ORV programs to CDC.
Given that economic considerations are central to the
use of ORV for rabies control, WS commissioned a
broad-based study that was initiated to try to put the high
costs of ORV in the context of long-term financial
benefits based on preventing the spread of raccoon rabies
westward (Kemere et al. 2002). Providing guidance for
this study was an early undertaking of the Rabies
Management Team. This study was designed to assess
the costs and benefits of a scenario-specific ORV strategy
to contain raccoon rabies from spreading to unaffected
areas west of the current distribution for raccoon variant.
The findings from this study were used help formulate
WS budget requests and proposals. The results of this
study are encouraging and along with other economic
studies (Uhaa et al. 1992, Meltzer 1996, Aubert 1999)
provide a basis for future analvses of increased
bphistication and sensitivity. ~conomicxwill continue to
be a ccntrd issue to ORV, given that c ~ n v e n t i o ~public
d

w
Figure 3. ORV zones by terrestrial wildlife rabies reservoir species in 2000.

F i i 4. ORV zones by terrestrial wildlife rabies reservoir species in 2001.

health approaches in the absence of ORV have succeeded
in preventing human rabies deaths.

X I 2 and Beyond
Completing ORV that began in 2001 to vaccinate
mountain gaps and other conidors that may facilitate the
spread of raccoon rabies to the west remains the highest

priority. The 2002 WS budget and cooperator resources
allow for this interim goal to be met through expansion of
the existing barrier from Lake Erie south to the high
mountain of eastem Tennessee (Appalachian Ridge
Project). In addition, other important initiatives in 2002
include: ORV expansion eastward into Pennsylvania,
continuing efforts in the Northeast, and a full restoration

Figure 5. Projected ORV zones by terrestrial wildlife reselYOU species and continued enhanced raccoon rabies
surveillance in Alabama in 2002.
of the gray fox ORV project in westcentral Texas (Figure
5). During 2002, about 4.2 million baits are projected to
be distributed at 75 baitsikm2 in the Appalachian Ridge
Project. The vaccination zone in Pennsylvania represents
the largest ORV effort in an area where raccoon rabies
has been enzootic, as well as the first time baiting will
occur in a major U.S. metropolitan area- the City of
Pittsburgh. Post-baiting evaluation will focus on two key
issues: the relationship of bait uptake and immunity
(based on serologic titers of virus neutralizing antibodies)
for a late summer bait drop (time of year), $nd for varying
bait densities (75, 150, and 300 baitsikm ). The results
will be compared to previous findings to evaluate optimal
baiting strategies.
In anticipation of ORV projects of increasing project
scope in 2002, the Rabies Management Team has
established 10 functional teams composed of diverse
expertise to address critical issues that are integral to
sound project evolution Qhble 2). Each team is charged
with evaluating state-of-the-art or science in each area and
recommending courses of action for the future.
The Contingency Action Planning Team has
evaluated practical alternatives to address rabies threats
that may compromise the integrity of ORV efforts. The
team is finalizing contingency action recommendations
that may be taken if: rabies intensifies approaching an
immure barrier; "hot spots" occur within a barrier; rabies
breaches a barrier, but is detected just beyond the
vaccination zone; or if rabies occurs as an isolated focus
sufticiently distant from a banier to suggest translocation,
intentional or unintentional, was the source of the focus.
The Communication Planning Team is developing a

variety of means to enhance interaction with the public on
ORV, including web site creation. However, an
immediate charge for this team is to bring together a l l key
interests including raccoon hunters, dog trainers,
rehabilitators, nuisance wildlife control operators, and
agency personnel to seriously address translocation of
rabies reservoir species, which could jeopardize national
efforts to control terrestrial variants of rabies.
Translocation of raccoons from the southeastern U.S. to
western Virginia and West Virginia in the late 1970s was
the probable origin of the epizootic mid-Atlantic region
that had not formerly experienced raccoon rabies (Nettles
et al. 1979).
Table 2. Ten interdisciplinary teams charged with
evaluating critical subject arras integral to effective
ORV and providing guidance to cooperative rabies
control planning.
Contingency Action Planning
Economic Analysis
ORV Evaluation
Baiting Support: Air and Ground
Su~eillance/Laboratory
Suppolt
Vaccine/Bait/Biomarker
Communications Planning
Research Prioritization
Baiting StrategiaslGIS Planning
NEPA Compliance

Figure 6. Preliminary planning projection for ORV zones by terrestrial wildlife reservoir species in 2003.
The Economic Analysis Team is providing guidance
on an analysis of the benefits and costs of a hypothetical
skunk rabies elimination progam with ORV in Santa
Barbara County, California. The results of this effort may
provide a foundation for future statewide and national
analysis for skunk rabies control.
The ORV Evaluation Team is formulating
standardized approaches to assess the integrity of ORV
efforts. Standardization will make comparisons among
projects more meaningful. The ability to evaluate project
progress will hinge heavily on CDC in the form of
reference laboratory support, testing of surveillance
samples, serological analysis, and epidemiological
investigations. In addition, the Surveillance Team has
recommended that the Rabies Laboratories in New York
and Virginia provide additional regional support for
ORV.
The other teams (Table 2) are focusing on a variety
of issues, including: new oral vaccines to complement the
existing recombinant vaccine (Hanlon et al. 2002), NEPA
analysis for ORV on National Park-managed lands, air
delivery capability alternatives for the future, and WS and
external research priorities to close important gaps in ow
understanding of ORV.
NWRC scientists began several research initiatives
in U X ) 2 designed to enhance ow understanding of ORV
strategies, rabies reservoir species, and non-target species
issues. The relationship of bait uptake to bait and target
species density is a priority project planned for
Pennsylvania that will allow for comparison to a similar
study conducted in Ohio in 1999, once those results are
published. Other studies include: vaccinia (the virus
vector for rabies glycoprotein in Raboral V - R G ~
dynamics in captive commensal rodent populations,

placebo bait preference in skunks in the westem U.S., and
bait uptake by raccoons in Ohio. WS operations, in
collaboration with NWRC, will continue to apply its
raccoon density index protocol and complete a 2-year
project that began in 2001, designed to assess variation in
density indices associated with plot size and trapping
effort.
The WS Rabies Control Business Plan,
Progammatic Environmental Assessment for ORV
(USDA 2001), and Strategic Plan, as well as other
supporting documentation (e.g., Hanlon et al. 1999) will
serve as foundation to develop a more comprehensive
National Rabies Management Plan. This plan will
provide guidance and recommendations for linking
regional raccoon rabies control plans, additional
initiatives to be taken to ensure that ORV technology
becomes available for use in the field for skunks and
mongooses,
ORV surveillance, and
research
prioritization, as well as other key planning issues.
The 2003 budget projection for WS looks promising,
with the President's budget recommending a $13.7
million increase. Decisions on ORV in Alabama, where
raccoon rabies appears to now to be slowly spreading
westward, will be based on enhanced raccoon rabies
surveillance that has been conducted in Alabama since
2000. If an ORV zone is justified in Alabama on the
basis of contemporary enhanced surveillance, it would
represent the largest new initiative during 2003 (Figure 6).
Planning and research will continue on prospective baits
and oral vaccines for us$ in skunks that could also
complement Raboral V-RG . Effort will also be directed
toward GIs analysis of baiting strategies that may have
applicability in terrestrial rabies elimination. Ensuring
adequate surveillance to measure ORV needs and

associations of rabies in rodents and lagomorphs in the
United States, 1985-1994. J. Wid. Dis. 33(1):20-27.
m o u c t ~ M.
, G., P. I. WWN, K A ClARK, D. R
SMIIH, D. H. JOHNSTON, B. N. HICKS,and G. M. MOORE.
1998. Results of an oral rabies vaccination program for
SUMMARY AND CONCLUSIONS
coyotes. I. Am. Vet. Med. Assoc. 212(4):498-502.
ORV shows promise as a control method for specific WEN,
D. B, and L F. ROBINSON.1993. Rabies. N. Engl. I.
rabies virus variants that persist in wildlife reservoirs in
Med. 329(22):1632-1638.
the U.S. As a result of increased public interest HANLON, C. A, I. E. CHILDS, V. F. NFI?1ES, and THE
NAXONALWORKING GROWON RABIES PEWNTION AND
manifested through the U.S. Congress, WS received
increasing federal funding to mperate in and help
CONTROL1999. Special seriesRecommendationsof a
coordinate multi-state efforts to control rabics in
national working group on prevention and control of rabies
terrestrial carnivores. In 2001, the ORV zone established
in the United States, Article 111: Rabies in wildlife. I. Am.
in Ohio beginning in 1997 was extended southward to
Vet. Med. Assoc. 215(11)1612-1619.
southern West Virginia to prevent raccoon rabies from HANLON, C. A, M. NlEZGOD.4, A N. HAhmR, C SCHUh4ACHER,
spreading west and compromising the commitment in
H. KOPROWSKI,
and C. E. RWPRFJ~K.
1998. Fit North
place in Ohio. The ORV zone will also be extended south
American field release of a vaccinia-rabies glycoprotein
in 2002 to interface with the high mountains in east
recombinant virus. J. Wild. Dis. 34(2):228-239.
Tennessee, in an attempt to integrate favorable geographic HANLON, C. A, M. NlEZGOD.4, P. M O W and C. E.
features with the vaccination zone to create a "barrier" at
R w P ~ 2002.
.
Oral efficacy of an attenuated rabies
reduced cost to prevent raccoon rabies form spreading to
virus vaccine in skunks and raccoons. I. Wildl. Dis.
new areas to the west. Enhanced surveillance currently in
38(2):420-427.
place in Alabama will provide data on the course of action HANLON, C. A, and C. E. RUPPRECHT.
1998. The reemergence
to take from the southern end of the Appalachians to the
of rabies. Pp. 59-80 in: W. M. Scheld, D. Armstrong, and
Gulf of Mexico. The cooperative gray fox ORV project
J. M. Hughes (eds.), Emerging Infections. ASM Press,
in west-central Texas has been restored to its original
Washington D.C.
schedule through cooperative federal funds and WS KFMFAE, P., M. K IDDEX, P. EVANG!30U, D. SLATE, and S.
participation with the Texas Department of Health as the
OsMm 2002. Economic analysis of a large scale oral
iead agency.
vaccination program to control raccoon rabies. In: L
Other key steps being taken with guidance from the
Clark, (ed.), Human Conflicts with Wildlife: Economic
Rabies Management Team include: ensuring adequate
Considerations. USDA National Wildlife Research
surveillance, pursing additional safe and effective oral
Center, Fort Collins, CO. (In Press)
vaccines, conducting priority research to address data KREBS,J. W, J. S. S m C. E. R w P ~ and
, I. E. CHnns.
gaps so that decisions remain science-based, addressing
2000. Mammalian reservoirs and epidemiology of rabies
translocation of rabics reservoir species near ORV
diagnosed in human being in the United States, 1981projects, and developing and implementing effective
1998. Ann. NY Acad. Sci. 916345-353.
communication strategies. Economic analysis and NEPA KREBS, J. W., A M. MONDUI, C. E. RWPRIXH&and 1. E
compliance have been identified as critical elements of an
CHILDS. 2001. Rabies surveillance in the United States
evolving ORV program with national goals and
during 2000. I. Am. Vet. Med. Assoc. 219(12):1687objectives. The stability of ORV programs in the near
1699.
tern will be critical to evaluate if such programs can be KREBS, 1. W., S. C. L O N G W , and 1. E. C H I D S . 1998.
optimized to effectively meet long-term objectives of
Causes, costs, and estimates of rabies postexposure
partial or full elimination of specific rabies virus variants
prophylaxis treatments in the United States. I. Public
in terrestrial wildlife reservoirs.
Health Manage. Pract. 4(5):56-62.
LAMBUT, M., E. BLASCO, I. BARRAT, F. QraW, B.
~TURECITED
BROCHFR, C. RENDERS, N. KRAFIT, I. BAELY, M.
AUBERT,M. F., E. MASON, M. ARrnB, and J. BARRAT.1994.
MVNIER, M. F. AUBERT, and P. P. PASOFLET. 2001.
Oral wildlife rabies vaccination field trials in Europe, with
Humoral and cell-mediated immune responses of foxes
recent emphasis on France. Curr. Top. Microbiol.
(Vulpes vulpes) after experimental primary and secondary
Immunol. 187:219-243.
oral vaccination usine, SAG2 and V-RG vaccines. Vaccine
AUBERT,M. F. 1999. Costs and benefits of rabies control in
1!3(13-14):1827-1835.
wildlife in France. Rev. Sci. Tech. 18(2):533-543.
MACINNES, C. D., and C. k LEBER. 2000.
Wildlife
BAER, G. M., M. K ABEISW and J. G. DEBBIE. 1971. Oral
management agencies should participate in rabies controL
vaccination of foxes against rabies. Am. I. Epidemiol.
Wildl. Soc. Bull. w4):1156-1167.
93(6):487-490.
MCQWTON, 1. H., P. A YAGEX, J. S. S m and C. E.
CZIILDS, J. E., L COLBY, I. W. KREBS, T. STNNE, M. FELLER,
R W P W . 2001. Epidemiologic characteristics of
D. NOAH, C. DJ. S. SMIIH, and C. E.
rabies virus variants in dog and cats in the United States,
R w P F ~ ~1997.
.
Surveillance and spatiotemporal
1999. I. Am. Vet. Med. Assoc. 218(12):1939-1942.
progress will remain a priority. A benefit:cost analysis
focusing on the dynamic of raccoon rabies variant
elimination is in the early planning stage and scheduled to
begjn in 2003.

Ma-

M. I. 19%. Assessing the costs and benefils of an
oral vaccine for raccoon rabies: a possible model. Emerg.
Infect. Dis. 2(4):343-349.
Mn.M. I., D. BROOKS,S. KRENDE& M MCGUU& B.
C ~ ~ E NA, DEMARIA, L ~q
C. H A N L OC.
N ,E.
RUPPRECHT, and K Shlmt 1997. An update on some
aspects of the economics of using an oral vaccine to
control raccoon rabies.
(Abstract).
8' Annual
International Meeting on Research Advances and Rabies
Control in the Americas, Kingston, Ontario, Canada
M a X Z R , M. I., and C. E. RUPPREQlT. 1998a A review of the
economics of the prevention and control of rabies. Part 1:
Global impact and rabies in humans. Pharmacoecon.
14(4):365-383.
hfELM. I., and C. E. R U P P R E ~1998b.
.
A review of the
economics of the prevention and control of rabies. Part 2:
Rabies in dogs, livestock and wildlife. Pharmacoecon.
14(5):481-498.
M E S ~ F., X, D. B. Fsm, and H. C. MATIER. 1994.
Rationale and prospxts for rabies elimination in
developing countries. Curr. Top. Micmbiol. Immunol.
187:l-26.
NET'IIES, V. F., J. H. SHADwCy R K SIKES,and C. R. RFYES.
1979. Rabies in translocated raccoons. Am. J. Public
Health. 69(6):601602.
NOAH,D. L, M. G. Shmq J. C. GOTIHARDT,J. W. KREBS, D.
GREEN,and J. E. QmDS. 1996. Mass human exposure to
rabies in New Hampshire: exposures, treatment, and cost.
Am J. Public Health. 86(8 Pt. 1):1149-1151.
OLSON, C. k ,K D.
and P. k WERNER. 2000. Bait
ingestion by free-ranging raccoons and nontarget species in
an oral rabies vaccine field trial in Florida. J. Wildl. Dis.
36(4):734-743.
ORCL4RJ, L k ,N. NEZGODA, C. A HANLON, 1. H. SHADDOD. W. SANDERLDV, P. A YAGER,and C. E. RWPRECHT.
2001. Rapid clearance of SAG-2 rabies virus from dogs
after oral vaccination. Vaccine 19(31):4511-4518.
ROBBNS, A H, M. D. BORDEN, B. S. WINDMILLER,M.
NEZCQDA, L C. MARCUS, S. M. O'BRIEN, S. M.
KRErND4 M W. MCGUUI, A D E W JR., C. E.
RWPRECHT, and S. RO1998. Prevention of the
spread of rabies to wildlife by oral vaccination of raccoons
in Massachusetts. J. Am. Vet. Med. Assoc. 213(10):14071412.
ROSATE, R, D. DONOVAN, M AUAN, L A H O W , A
SL.vER, K B m , C. IMAc-,
C. D A ~ A,
WANDELFX, and B. RADFORD. UX)1. Emergency
response to raccoon rabies introduction into Ontario. J.
Wildl. Dis. 37(2):265-279.
ROSWE, D. E., W. C. HOLSIE,F. E. SORHAGE, C. CAMPBELI,
M.NEZGODA, R BUCXANNAN, D. D m H. S. NN, and
C. E. RWPREQlT. 1998. Efficacy of an oral vaccinia-

rabies glycoprotein recombinant vaccine in controlling
epidemic raccoon rabies in New Jersey. J. Wildl. Dis.
34(4):752-763.
SIEMER,W. F., and T. L BROWN. 1994. Public perceptions of
rabies and proposed oral bait vaccination trial. HDRU
Series Pub. 94-7. Cornell University, Ithaca, NY. 38 pp.
s m , K A , R. K R o w , F. S q R. HALE, M. CDLZART,
and C. CRAIG. 1999. The Ohio ORV program. (Abstract).
10' International Meeting on Research Advances and
Rabies Control in the Americas, San Diego, C A
S m J. S. 1989. Rabies virus epitopic variation: use in
ecologic studies. Adv. Virus. Res. 36:215-253.
Shmq J. S., L A ORCIARI, P. k YAGER, H. D. SEIDEb and C.
K WARNER. 1992. Epidemiologic and historical
relationships among 87 rabies virus isolates as determined
by limited sequence analysis. J. Infed. Dm. 166(2):296307.
S m J. S. 19%. New aspeas of rabies with emphasis on
epidemiology, diagnosis, and prevention of the d i i in
the United States. Clin. Microbiol. Rev. 9(2):166-176.
F., A WANDELER,
CAPT. P. BICHSG U. HAFLIGER, and
L. G. SCllNEDER. 1982. Oral immunization of foxes
against rabies. Laboratory and field studies. Comp.
Immunol. Microbiol. Infect. Dis. 5(1-3):165-172.
Smw K, and F. M. MESm. 1996. Progress and setbacks in
the oral immunization of foxes against rabies in Europe.
Vet. Rec. 139(2):32-35.
UHAA,I. J., V. M. D A ~F., E. SORHAGE, J. W. BFGuEY, D. E.
ROSCOE, R. D. GORSKY,and D. B. FISHBEIN. 1992.
Benefits and costs of using an orally absorbed vaccine to
control rabies in raccoons. J. Am. Vet. Med. Assoc.
201(12):1873-1882.
USDA 2001. Environmental Assessment- Oral vaccination to
control specitic rabies virus variants in raccoons, gray
foxes, and coyotes in the United States. United States
Department of Agriculture, Animal and Plant Health
Inspenion Service, Wildlife Services, Riverdale, MD. 54
PP.
WAND= A I. 1991. Oral immunization of wildlife. Pp.
485-503 in: G. U Baer (ed.), The Natural History of
Rabies. CRC Press, Boca Raton, FL
WAND^ A 1. 2000. Oral immunization against rabies:
afterthoughts and foresight. Schweiz. Arch. Tierheilkd.
142(8):455-462.
W m R , T. J., and H KOPROWSKL 1978. Monoclonal
antibodies against rabies virus produced by somatic cell
hybridization: detection of antigenic variants. Proc. Natl.
A d Sci., USA 75(8):3938-3942.
ZANoNJ, R G., A KAPPELER, U. M MULLER, C MULLER, A I.
WANDand U. BREIIENMOSER. 2000. Rabies-free
status of Switzerland following 30 years of rabies in foxes.
Schweiz. Arch. Tierheilkd. 142(8):423-429.

